RK

Rakesh Kaul

Active Director Designated Partner DIN 08316888
DIN 08316888 First appointment Dec 2018 Primary industry Consumer Electronics & Durables
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2018
Shareholding value β€’β€’β€’β€’ Premium profile

About Rakesh Kaul

Data last updated:

Rakesh Kaul is a Designated Partner at Eyemax Ophthalmics (India) Llp (since 2018). The company operates in Consumer Electronics & Durables.

DIN 08316888
Primary Designation Designated Partner
Industry Consumer Electronics & Durables
First Appointment 31 Dec 2018
Oldest Company Age 7 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner31 Dec 20182018Active

Board colleagues of Rakesh Kaul

NameDINCompanyDesignation
Manish Pandey08316889Eyemax Ophthalmics (India) LlpDesignated Partner
Nutan09088536Eyemax Ophthalmics (India) LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Eyemax Ophthalmics (India) Llp
Premium access

Shareholding and investment profile for Rakesh Kaul

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rakesh Kaul

Rakesh Kaul currently holds 1 directorship: Eyemax Ophthalmics (India) Llp (Designated Partner, since 31 Dec 2018).

Rakesh Kaul was first appointed on 31 Dec 2018 as Designated Partner at Eyemax Ophthalmics (India) Llp.

The current boards of Rakesh Kaul's companies include Manish Pandey (Eyemax Ophthalmics (India) Llp), Nutan (Eyemax Ophthalmics (India) Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available